Which chemo works best before esophageal cancer surgery? new study aims to find out
NCT ID NCT02359968
First seen Mar 24, 2026 · Last updated May 25, 2026 · Updated 11 times
Summary
This study looked at 106 people with esophageal or junction cancer that could be removed by surgery. Before surgery, patients received either a standard three-drug chemo (FOLFOX) or a two-drug combo (paclitaxel plus carboplatin) along with radiation. The goal was to see which approach leads to more complete tumor removal and fewer serious complications after surgery. The results help doctors choose the best treatment plan.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRO-ESOPHAGEAL JUNCTION CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CH Lyon sud
Pierre-Bénite, France
-
CHU Bordeaux
Bordeaux, France
-
Centre Eugène Marquis
Rennes, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Hôpital La Timone
Marseille, France
-
Hôpital Nord
Marseille, France
-
ICM - Val d'Aurelle
Montpellier, France
-
ICO Paul Papin
Angers, France
-
ICO René Gauducheau
Saint-Herblain, France
-
University Hospital of Lille
Lille, 59000, France
Conditions
Explore the condition pages connected to this study.